您的位置: 首页 > 农业专利 > 详情页

Pharmaceutical composition of solifenacin or salt thereof for use in solid formulation and use of substance with ethylene oxide chain
专利权人:
ASTELLAS PHARMA INC.
发明人:
SUGIHARA AKIO,YASUJI TAKEHIKO,MASAKI KATSUHIRO,MURAYAMA DAISUKE
申请号:
SK50202011
公开号:
SK50202011U1
申请日:
2005.03.24
申请国别(地区):
SK
年份:
2012
代理人:
摘要:
A solid pharmaceutical preparation of solifenacin or a salt thereof, the preparation being stable and inhibited from decomposing with time when supplied to clinical fields. In a pharmaceutical preparation containing solifenacin or a salt thereof, the compound in an amorphous form was revealed to be causative of cardinal-drug decomposition with time. The composition for a solid pharmaceutical preparation of solifenacin or a salt thereof contains solifenacin or its salt each in a crystalline from, and the content provided are: a process for producing the composition; and a medicinal composition for solid pharmaceutical preparations which contains solifenacin and an amorphization inhibitor.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充